OsterAM, SternbergM, LanskyA, et al.Population size estimates for men who have sex with men and persons who inject drugs. J Urban Health, 2015; 92:733–743.
2.
KrakowerDS, MimiagaMJ, RosenbergerJG, et al.Limited awareness and low immediate uptake of pre-exposure prophylaxis among men who have sex with men using an internet social networking site. PLoS One, 2012; 7:e33119.
3.
GrantRM, LamaJR, AndersonPL, et al.Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med, 2010; 363:2587–2599.
4.
LiuA, CohenS, FollansbeeS, et al.Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco. PLoS Med 2014 Mar, 4; 11(3): e1001613. doi: 10.1371/journal.pmed.1001613.eCollection 2014.
5.
MarcusJL, GliddenDV, MayerKH, et al.No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis. PLoS One, 2013; 8:e81997.
6.
YoungI, McDaidL. How acceptable are antiretrovirals for the prevention of sexually transmitted HIV? A review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS Behav, 2014; 18:195–216.
7.
GolubSA, GamarelKE, RendinaHJ, SuraceA, Lelutiu-WeinbergerCL. From efficacy to effectiveness: Facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care STDS, 2013; 27:248–254.
8.
HojillaCJ, KoesterK, CohenSE, et al.Sexual behavior, risk compensation, and HIV prevention strategies among participants in the San Francisco PrEP demonstration project: A qualitative analysis of counseling notes. AIDS Behav, 2015. DOI: 10.1007/s10461-015-1055-5.
9.
LiuAY, HessolNA, VittinghoffE, et al.Medication adherence among men who have sex with men at risk for HIV infection in the United States: Implications for pre-exposure prophylaxis implementation. AIDS Patient Care STDS, 2014; 28:622–627.
10.
KrakowerD, MayerKH. Engaging healthcare providers to implement HIV pre-exposure prophylaxis. Curr Opin HIV AIDS, 2012; 7:593–599.
11.
KrakowerD, WareN, MittyJA, MaloneyK, MayerKH. HIV providers' perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: A qualitative study. AIDS Behav, 2014; 18:1712–1721.
12.
ArnoldEA, HazeltonP, LaneT, et al.A qualitative study of provider thoughts on implementing pre-exposure prophylaxis (PrEP) in clinical settings to prevent HIV infection. PLoS One, 2012; 7:e40603.
